Novartis and Microsoft have inked a five-year deal to use artificial intelligence to design molecules, personalize medication dosing, and optimize the manufacturing of CAR-T cancer therapy, the two companies announced Tuesday. The partnership, whose financial terms were not disclosed, marks the latest and one of the more high-profile signs of the inroads that tech is making into drug development. It promises benefits for both sides: Novartis (NVS) will get Microsoft’s help in mining data i...
READ MORE
|
The pharma and biotech industry has been hit badly by concerns over high drug prices in the past few years. The initial panic was triggered in September 2015 when the Democratic presidential candidate Hillary Clinton tweeted about "price gouging" and laid out a proposal for combating skyrocketing drug prices....
READ MORE
|
As government officials continue to scrutinize the high costs of many drugs, particularly the price of life-saving insulin, Indianapolis-based Eli Lilly disclosed data over the weekend that indicates the price for its lead insulin product Humalog dropped by 8 percent over the past five years. In its disclosure, Eli Lilly said that pricing of medications is one of its biggest and most important decisions. Eli Lilly said that across its product portfolio in the United States, the average net price...
READ MORE
|
Ionis Pharmaceuticals’ RNA-targeted drug Waylivra has been conditionally approved in Europe for the devastating ultra-rare disease Familial Chylomicronemia Syndrome (FCS). The European Commission’s conditional approval means Ionis and its affiliate Akcea will have to re-apply for a marketing authorisation each year for Waylivra (volanesorsen), until they can present confirmatory data to the regulator. As part of the conditional marketing authorisation, Akcea and Ionis will conduct a ...
READ MORE
|
Let’s say your company has developed a drug for adults with ADHD. However, fewer than 20% of adults with ADHD are currently diagnosed by psychiatrists, in part because ADHD presents differently in adults than it does in children (1). Your company wants to change that through a digital strategy that both helps raise awareness of adult ADHD, and also provides....
READ MORE
|
In the last decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients’ treatment options and significantly improved outcomes, helping people with RA achieve disease remission....
READ MORE
|